Schedule 13D ownership disclosure
Innate Pharma SA
Security class unavailable · CUSIP: 45781K105
Event date: 2019-10-16
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 7,485,500
- Percent of class
- 9.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-19-056493
- Form type
- SC 13D
- Filer
- ASTRAZENECA PLC
- CIK
- CIK 901832
- Filed
- Oct 25, 2019
- Reporting period
- Oct 16, 2019
- Description
- Schedule 13D beneficial ownership